Interleukin-6 (IL-6) is a key cytokine mediating multiple inflammatory responses, and its expression is significantly elevated in the serum and joint synovial fluid of RA patients, making it an important therapeutic target for RA (5). This evidence concerns the gene IL6 and rheumatoid arthritis.